BMY Bristol-Myers Squibb Company

Healthcare

Price

$59.59

Intrinsic value

$27.82

Buy price

$22.26

Discount

-114.2%

Overvalued

Live signals (1)

Daily bars as of Oct 8, 2026

IBB-DownsideInside Bar Breakout (downside)Bearish ↓
An inside bar coiling inside a strong bearish mother bar, with price holding below the 50-day SMA - a pause before the next leg down.
Fired Oct 6, 20262 daily bars ago23.8% win rate · 0.56x profit factor

A pattern is reported for 5 bars after it fires (the sweet-spot fill window), so an older bar count means the entry has had longer to play out - not that the signal is stronger. Win rate and profit factor are the pattern's backtested averages across the S&P 500, not a forecast for this ticker.

DCF walkthrough

Near-term growth (g1)1.45%

Terminal growth (g2)3.50%

Years of g1 growth4

Discount rate9.00%

Margin of safety20.00%

Operating CF: $12,782,000,000.00
Total debt: $45,053,001,728.00
Cash & STI: $11,066,999,808.00
Shares out.: 2,048,000,000

Overvalued

Intrinsic value$27.82

Buy price (with MOS)$22.25

Current price$59.59

Discount to intrinsic value-114.2%

7-step quality scorecard

ROE quality

LOW

Average ROE: 7.8%
Current ROE: 38.2%
Minimum ROE: -54.8%

Debt quality

LEVERAGED

Debt / Equity: 2.44x

Moat proxy

MODERATE_PROXY

Cash-flow reliability

Operating CF / Net income: 1.38x

Technical chart

Confluence: DOWNTREND (1/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim (see Live signals above for when it fired).

Assumptions & data quality

Data source: yfinance
Growth (g1) source: min(revenueCAGR,cfCAGR)
Valuation model: DCF_OCF
Debt as % of DCF PV: 49.5%
Public economic interest: 99.8%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.